Ariel Capital Advisors »

Iovance Biotherapeutics shares owned by Ariel Capital Advisors

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Ariel Capital Advisors from 13F filings

Historical chart of Ariel Capital Advisors investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Ariel Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Ariel Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $320k 43k 7.40

More positions owned by Ariel Capital Advisors

NVIDIA Corporation (NVDA)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Apple (AAPL)
Microsoft Corporation (MSFT)
JPMorgan Chase & Co. (JPM)
Vanguard Bd Index Fds Vanguard Ultra (VUSB)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr Russell 2000 Etf (IWM)
Costco Wholesale Corporation (COST)
Palo Alto Networks (PANW)
Visa Com Cl A (V)
Vanguard Scottsdale Fds Int-term Corp (VCIT)

View all positions for Ariel Capital Advisors

Top funds holding Iovance Biotherapeutics

BlackRock
MHR Fund Management
Vanguard Group
State Street Corporation
Invenomic Capital Management
Goldman Sachs Group
Long Focus Capital Management
Geode Capital Management
Palo Alto Investors
Susquehanna International
Citadel Advisors
Millennium Management
Hrt Financial
Jane Street
Charles Schwab Investment Management

View all funds holding Iovance Biotherapeutics